VAERS 2429002
MERCK & CO. INC. · ROTAVIRUS (ROTATEQ) · Charge U037810
- Staat
- PA
- Alter
- 0,3
- Geschlecht
- M
- Eingang
- 05.09.2022
- Impfdatum
- 31.05.2022
- Beginn
- 25.06.2022
- Tage bis Beginn
- 25,0
- Dosis
- 2
- Route/Site
- PO / MO
Symptomtext
He developed a small bowel to small bowel intussusception on June 25, 2022 which spontaneously reduced. This occurred in the midst of persistent diarrhea which started the week of his 2nd dose of Rotateq. The diarrhea continued to increase. By June 14, was having diarrhea every 10-15 minutes and vomiting. Seen in ER, no change in plan. Then within a few days developed blood in stool which became more intense and associated with pain and sent to ER where the US showed a small bowel to small bowel intussusception which reduced. Admitted overnight. Mom had been dairy free for months. Subsequenttly bloody stools resolved after elimination of soy from maternal diet as well
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Diarrhoea
- Hospital-Tage
- 1,0
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- healthy infant but hx of premature at 33 3/7 weeks gestation. Stat c/s due to fetal heart rate abnormality. Apgars 3 and 8. Brief resp support but on RA by 1-29-22. Hyperbili and phototherapy. Apnea of prematurity. Was exposed to parents who had COVID19 at the time of his birth. Infant COVID19 negative. Received amp and gent briefly but sepsis ruled out. All issues resolved prior to NICU discharge. Mild left pelvocaliectasis on left with a renal calculus/calculi
- Andere Medikamente
- poly-vitamin with iron 1 ml daily breastmilk fortified with neosure
- Allergien
- subsequent diagnosis of allergic procto-colitis to cow milk protein and soy (clinical diagnosis and dietary elimination). Mom had eliminated dairy prior to possible vaccine reaction
- Vorherige Impfungen
- -